| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9936 |
| Human Intestinal Absorption | HIA+ | 0.9971 |
| Caco-2 Permeability | Caco2+ | 0.8852 |
| P-glycoprotein Substrate | Non-substrate | 0.7524 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9436 |
| Non-inhibitor | 0.9764 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8582 |
| Distribution |
| Subcellular localization | Lysosome | 0.5722 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7390 |
| CYP450 2D6 Substrate | Substrate | 0.5415 |
| CYP450 3A4 Substrate | Non-substrate | 0.6993 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6531 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8429 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8605 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7263 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9534 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8236 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9595 |
| Non-inhibitor | 0.9664 |
| AMES Toxicity | Non AMES toxic | 0.9687 |
| Carcinogens | Non-carcinogens | 0.7604 |
| Fish Toxicity | High FHMT | 0.6121 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9462 |
| Honey Bee Toxicity | Low HBT | 0.6589 |
| Biodegradation | Not ready biodegradable | 0.7689 |
| Acute Oral Toxicity | III | 0.5740 |
| Carcinogenicity (Three-class) | Non-required | 0.7475 |